MKI67 and neoplasm: This study aimed to assess whether long-term metformin use is associated with less aggressive clinicopathological features—such as tumor size, Ki-67 expression, degree of differentiation, TNM stage, and nodal involvement—in patients with T2DM and invasive LUAD who underwent curative surgery.